The site will be unavailable in 6 minutes for scheduled maintenance.

$2.93 -0.10 (-3.30%)
2/10/2012 4:00 PM

AVANIR Pharmaceuticals (NASDAQ:AVNR)

CAPS Rating: 2 out of 5

A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.

Featured Broker Partners


Advertisement